Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
Open Access
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14 (9) , 816-827
- https://doi.org/10.1111/j.1469-0691.2008.02061.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Development of Colistin-DependentAcinetobacter baumannii-Acinetobacter calcoaceticusComplexAntimicrobial Agents and Chemotherapy, 2007
- Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trialsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain*Critical Care Medicine, 2007
- Colistin Is Effective in Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa in Cancer PatientsAntimicrobial Agents and Chemotherapy, 2007
- Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa StrainAntimicrobial Agents and Chemotherapy, 2007
- Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICUInternational Journal of Antimicrobial Agents, 2006
- Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2006
- In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised PatientsAntimicrobial Agents and Chemotherapy, 2005
- Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibioticClinical Microbiology & Infection, 2005
- In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibioticsClinical Microbiology & Infection, 1999